| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults (NCT04645147) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-29 |
| PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. (NCT03755440) | Sun Yat-sen University | 2018-12-01 |
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial (NCT03699904) | Belfast Health and Social Care Trust | 2018-10-11 |
| Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation (NCT02878278) | Huiqiang Huang | 2016-09-01 |
| Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis (NCT03650231) | Centre Hospitalier Universitaire, Amiens | 2015-01-01 |
| A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (NCT02007356) | University Hospital, Basel, Switzerland | 2014-12-01 |
| Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (NCT01948180) | Cell Medica Ltd | 2014-09-01 |
| Belatacept 3 Month Post Transplant Conversion Study (NCT02213068) | Lorenzo Gallon | 2014-07-01 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors (NCT02080416) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-07-01 |
| CNTRP POSITIVE Study (NCT02318030) | The Hospital for Sick Children | 2014-04-01 |
| Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) (NCT01945814) | Catherine Bollard | 2014-02-01 |
| Cytotoxic T Cells to Prevent Virus Infections (NCT01923766) | Children's National Research Institute | 2013-09-01 |
| Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation (NCT02779439) | University of Sydney | 2013-01-01 |
| Plasma EBV DNA Monitoring in Post-treatment NPC Patients (NCT03973723) | Taichung Veterans General Hospital | 2011-08-01 |
| The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise (NCT01011712) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |